Ads
related to: robotic process automation software
Search results
UiPath Stock Dives. Cathie Wood’s Favorite AI Play Is Struggling.
Barrons.com· 7 hours agoARK Invest head Wood has cited UiPath as a winner from the boom in artificial intelligence despite...
UiPath Faces Challenges: CEO Departure, Lowered Forecasts, and Internal Setbacks
GuruFocus.com via Yahoo Finance· 2 hours agoA mix of internal and external headwinds in Q1 (Apr) has significantly impacted UiPath (NYSE:PATH), causing a sharp decline in its growth trajectory. Despite exceeding analyst earnings and sales ...
UiPath stock target cut, maintains neutral rating on recent earnings report By Investing.com
Investing.com· 3 hours agoOn Thursday, Mizuho has revised its stock price target for UiPath Inc. (NYSE:PATH), a leading ...
UiPath's stock plummets as CEO Rob Enslin abruptly resigns and guidance disappoints - SiliconANGLE
SiliconANGLE· 21 hours agoShares of the automation software company UiPath Inc. were battered in after-hours trading today,...
UiPath to Re-Appoint Daniel Dines as Chief Executive Officer; Rob Enslin Steps Down as CEO and Board...
Morningstar· 1 day agoUiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced Rob Enslin is resigning as Chief Executive Officer and member ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 1 day agoLaboratory Automation Systems Market size is set to grow by USD 2.01 billion from 2024-2028, Increasing demand for laboratory automation software ...
PINpoint Information Systems to Showcase Innovative MES Solutions at the Smart Manufacturing...
Digital Journal· 5 hours agoWith a proven track record of success across major industrial sectors, PINpoint...engage with interactive exhibits, attend insightful sessions, and network with peers to gain actionable insights ...
UiPath stock downgraded by TD Cowen amid CEO exit and outlook concerns By Investing.com
Investing.com· 12 hours agoOn Thursday, TD (TSX:TD) Cowen adjusted its stance on UiPath Inc. (NYSE:PATH) stock, shifting from a...
Cellular Origins and CGT Catapult partner to automate cell and gene therapy manufacturing
BioPharma-Reporter· 10 hours agoBy combining CGT Catapult’s expertise in GMP operations with Cellular Origins’ Constellation, the...
UiPath Stock Plunges Nearly 30% as CEO Rob Enslin Abruptly Resigns
Analytics India Magazine· 17 hours agoAnalysts said the abrupt CEO change indicates Enslin's failure to drive faster growth, and weak guidance suggests deeper issues at UiPath
Ads
related to: robotic process automation software